JOSEF; Kurt A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for JOSEF; Kurt A..The latest application filed is for "uracil derivatives as axl and c-met kinase inhibitors".

Company Profile

0.17.13

JOSEF; Kurt A. - San Diego CA
Josef; Kurt A. - Radnor PA
Josef; Kurt A. - Wayne PA
Josef; Kurt A. - Clifton Park NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20170320853 - DANDU; Reddeppa Reddy ; et al.	2017-11-09
Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,745,283 - Dandu , et al. August 29, 2	2017-08-29
Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20170050949 - Dandu; Reddeppa Reddy ; et al.	2017-02-23
Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,522,902 - Dandu , et al. December 20, 2	2016-12-20
Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,120,778 - Dandu , et al. September 1, 2	2015-09-01
Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20150210670 - Dandu; Reddeppa Reddy ; et al.	2015-07-30
Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20150209358 - Dandu; Reddeppa Reddy ; et al.	2015-07-30
Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,029,538 - Dandu , et al. May 12, 2	2015-05-12
Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20140275077 - Dandu; Reddeppa Reddy ; et al.	2014-09-18
Pyridazinone Derivatives App 20140142088 - Bacon; Edward R. ; et al.	2014-05-22
Methods of treating disorders mediated by histamine H.sub.3 receptors using pyridazinone derivatives Grant 8,673,916 - Bacon , et al. March 18, 2	2014-03-18
Aryl pyridazinone derivatives and their use as H3 receptor ligands Grant 8,586,588 - Bacon , et al. November 19, 2	2013-11-19
Pyrrolotriazines as ALK and JAK2 inhibitors Grant 8,471,005 - Breslin , et al. June 25, 2	2013-06-25
Pyridizinone derivatives and the use thereof as H3 inhibitors Grant 8,247,414 - Bacon , et al. August 21, 2	2012-08-21
Pyridazinone derivatives Grant 8,207,168 - Becknell , et al. June 26, 2	2012-06-26
Pyrrolotriazines As Alk And Jak2 Inhibitors App 20120028919 - Breslin; Henry J. ; et al.	2012-02-02
Pyridazinone Derivatives App 20110288075 - Bacon; Edward R. ; et al.	2011-11-24
Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands App 20110098269 - Becknell; Nadine C. ; et al.	2011-04-28
Pyridazinone Derivatives App 20100280007 - Bacon; Edward R. ; et al.	2010-11-04
Pyridazinone Derivatives App 20100273779 - Bacon; Edward R. ; et al.	2010-10-28
Pyridizinone derivatives App 20080027041 - Hudkins; Robert L. ; et al.	2008-01-31
3-amido-triiodophenyl esters as x-ray contrast agents Grant 5,668,196 - Robinson , et al. September 16, 1	1997-09-16
Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract Grant 5,336,484 - Bacon , et al. * August 9, 1	1994-08-09
Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract Grant 5,334,370 - Josef , et al. August 2, 1	1994-08-02
Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract Grant 5,326,553 - Illig , et al. * July 5, 1	1994-07-05
Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract Grant 5,316,755 - Illig , et al. * May 31, 1	1994-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.